Am J Otolaryngol Head Neck Surg | Volume 6, Issue 3 | Research Article | Open Access

Proposal for a New Clinical Treatment of Spontaneous Cholesteatoma of the External Auditory Canal with Clobetasol Propionate

Ribeiro FAQ^1*, Mitre EI¹, Dobrianskyj FM² and Kobayashi AF²

¹Department of Otorhinolaryngology, Faculty of Medical Sciences of Santa Casa de São Paulo, Brazil
²Department of Otorhinolaryngology, Irmandade da Santa Casa de Misericórdia de São Paulo, Brazil

^*Correspondance to: Fernando de Andrade Quintanilha Ribeiro 

Fulltext PDF

Abstract

Background: External Auditory Canal Cholesteatoma (EACC) is a disease in which the canal skin spontaneously acquires a hyperproliferative osteolytic nature leading to canal enlargement which can invade the middle ear and mastoid. The treatment of choice is generally surgical, while clinical approaches tend to be ineffective. Objective: To assess the outcomes of clinical treatment of cholesteatoma involving the external auditory canal only using clobetasol propionate. Material and Methods: Cases with spontaneous cholesteatoma of the EAC treated at the otologic surgery clinic of a university teaching hospital between 2011 and 2018 were assessed. The sample included only cases involving the EAC presenting no erosion into the mastoid cavity or tympanic membrane perforation. Results: Of the 18 cases followed, disease control was achieved in 14 (77.7%), whereas no improvement was observed in 4 cases (22.2%). Conclusion: Clinical treatment using Clobetasol Propionate controlled the disease in a large number of patients, precluding the need for traditional surgical procedures.

Keywords:

Cholesteatoma; External auditory canal; Surgery; Clobetasol propionate

Citation:

Ribeiro FAQ, Mitre EI, Dobrianskyj FM, Kobayashi AF. Proposal for a New Clinical Treatment of Spontaneous Cholesteatoma of the External Auditory Canal with Clobetasol Propionate. Am J Otolaryngol Head Neck Surg. 2023; 6(3):1235.